Walmart Settles Opioid Lawsuit for $50 Million
After nearly five years of legal proceedings, Walmart has settled a federal lawsuit with the Justice Department and DEA over its pharmacies filling invalid opioid prescriptions. The company agreed to pay $50 million, far below initial estimates that could have reached billions due to penalties per violation. Judge Colm Connolly significantly narrowed the case in March 2024 by dismissing key claims related to unreported suspicious orders and documentation failures. The lawsuit stemmed from allegations dating back to 2013, where Walmart was accused of prioritizing sales over safety despite internal warnings about "pill mills." The government argued that pharmacists flagged thousands of problematic prescriptions but were not adequately addressed. With most charges dismissed, the settlement allowed both parties to avoid further litigation. Financially, $50 million is considered immaterial for Walmart given its scale—equivalent to just 0.4% of its six-month net income and roughly one day’s operating profit.
Tickers: $WMT
Topics: federal regulation legal opioids pharmacies